Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Non-Hodgkin 14Leukemia, Myeloid, Acute 14Burkitt Lymphoma 14Lymphoma, Mantle-Cell 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Hodgkin Disease 13Lymphoma, Large-Cell, Immunoblastic 12Multiple Myeloma 11Leukemia, Myeloid, Chronic-Phase 11Blast Crisis 11Lymphoma, T-Cell, Cutaneous 10Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Hairy Cell 10Leukemia 10Leukemia, Myelomonocytic, Chronic 9Congenital Abnormalities 9Sezary Syndrome 8Mycosis Fungoides 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Lymphoma 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Neoplasms 6Lymphoma, Large-Cell, Anaplastic 6

Interventions

Thiotepa 3Melphalan 3Cyclophosphamide 3fludarabine phosphate 2fludarabine 2Busulfan 2Alemtuzumab 2Whole-Body Irradiation 1Therapeutics 1Tacrolimus 1PLX8394 1Muromonab-CD3 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Immunotherapy 1Drug Therapy 1Antilymphocyte Serum 1Antibodies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Therapeutics × Other hematologic neoplasm × Clear all
NCT01050439 2015-04-15

Unrelated Donor Transplant for Malignant and Non-Malignant Disorders

Columbia University

Phase 2 Terminated
22 enrolled
LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡